VivoSeq
Other

Female Pattern Hair Loss

0

Pipeline Programs↗

3

Active Trials↗

3

Companies Involved↗

Female Pattern Hair Loss is an early-stage landscape with 0 programs across 3 companies. The most active players are McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., Merz Pharmaceuticals GmbH, AbbVie.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

M

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

0 programs

PreclinicalM

Merz Pharmaceuticals GmbH

0 programs

PreclinicalAbbVie logo

AbbVie

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

12

clinical trials

Completed7 · 58%
Unknown status2 · 17%
Not yet recruiting2 · 17%
Recruiting1 · 8%

Clinical Trials

Trial Activity

12 trials

Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss
Recruiting·SSohag University·Phase 1/2·NCT06333600·45 enrolled
Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss
Not yet recruiting·EEMS·Phase 3·NCT05824065·504 enrolled
Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN)
Not yet recruiting·EEurofarma Laboratorios S.A.·Phase 3·NCT07303322·372 enrolled
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Completed·AApplied Biology, Inc.·N/A·NCT02206802·300 enrolled
Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss
Completed·UUniversity of British Columbia·Phase 2·NCT00175617·40 enrolled
Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss
Completed·SSohag University·Phase 4·NCT04090801·60 enrolled
Clinical Trial in Females With Female Pattern Hair Loss
Completed·MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.·Phase 3·NCT01145625·322 enrolled
A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss
Completed·MMerz Pharmaceuticals GmbH·Phase 2·NCT01900041·74 enrolled
Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss
Completed·AbbVie logoAbbVie·Phase 2·NCT01325350·306 enrolled
Clinical Trial in Females for Female Pattern Hair Loss
Completed·MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.·Phase 3·NCT01226459·404 enrolled
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
Unknown status·HHistogen·Phase 1·NCT03662854·27 enrolled
The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement
Unknown status·SSiriraj Hospital·Phase 1/2·NCT01662089·20 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)